RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.


Ann Decker

Research Pharmacologist


PhD, Synthetic Chemistry, University of Virginia
BS, Chemistry, College of William and Mary

Ann M. Decker, Ph.D., conducts preclinical in vitro research to characterize novel compounds at CNS G-protein coupled receptors and biogenic amine transporters. Dr. Decker has experience with cell culture and molecular biology techniques as well as in vitro assays such as FLIPR-based calcium mobilization, enzyme complementation, radioligand binding, and synaptosomal biogenic amine transporter release and uptake inhibition.     

Dr. Decker received training in synthetic and medicinal chemistry before making a career transition to pharmacology. Her background includes experience with the total synthesis of complex natural products and the synthesis of small molecule libraries. This unique combination of chemistry and pharmacology knowledge has led to Dr. Decker’s strong understanding of the relationship between chemical structure and biological activity.

Dr. Decker has been a co-author of more than 10 peer-reviewed articles in both disciplines and has presented at the Society for Neuroscience and the American Chemical Society national meetings. 

Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics